Our Mission
To empower radiologists and medical institutions with AI-driven diagnostic tools that improve the accuracy, speed, and accessibility of breast cancer screening — ensuring no cancer goes undetected.
Our Vision
A future where every woman — regardless of geography or access to medical resources — can benefit from early and accurate breast cancer screening, powered by AI technology built for women everywhere.
Our Team
Dr. Yi-Chiung Hsu
PhD in Pharmacology from National Yang Ming University. Professor at NCU Biomedical Engineering. Board Supervisor of Taiwan Exosome Society. PI of Ministry of Education Biomedical Data Analysis Program.
Dr. Jia-Ching Wang
PhD in Electrical Engineering from NCKU. Distinguished Professor at NCU Computer Science. Director of NCU Innovative AI Research Center. PI of NSTC AI Program.
Dr. Chen-Yen Chung
PhD in Immunology from University of Edinburgh. Assistant Professor at Soochow University. Founder of BioMed Inc. Executive Director of HaoYun Biomedical.
Milestones
Multi-lesion Model Development
Develop classification models covering multiple breast lesion types. Internal testing and platform stability optimization.
Clinical Validation Testing
Contact medical institutions for multi-center clinical data testing to ensure system effectiveness in real clinical environments.
Nationwide Data Validation
Collaborate with Taiwan NHA to initiate nationwide data validation including model fine-tuning and performance verification.
TFDA Registration Preparation
Prepare technical documentation, risk assessment, QMS documents, and performance reports for SaMD regulatory submission.
Market Development
Participate in domestic and international exhibitions. Establish spin-off company and conduct business development.
Healthcare System Integration
Interview potential users and decision makers. Evaluate front-end deployment with partner hospitals for smooth commercialization.
Multi-lesion Model Development
Develop classification models covering multiple breast lesion types. Internal testing and platform stability optimization.
Clinical Validation Testing
Contact medical institutions for multi-center clinical data testing to ensure system effectiveness in real clinical environments.
Nationwide Data Validation
Collaborate with Taiwan NHA to initiate nationwide data validation including model fine-tuning and performance verification.
TFDA Registration Preparation
Prepare technical documentation, risk assessment, QMS documents, and performance reports for SaMD regulatory submission.
Market Development
Participate in domestic and international exhibitions. Establish spin-off company and conduct business development.
Healthcare System Integration
Interview potential users and decision makers. Evaluate front-end deployment with partner hospitals for smooth commercialization.